Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin

Background: P120(ctn) is a specific membranous adhesion protein, that maintains the stability of intercellular junctions. An altered expression of p120(ctn), either reduced in the cell membrane or increase in the cytoplasm, plays a crucial role in carcinogenesis. No research has analysed the express...

Full description

Bibliographic Details
Main Authors: Vladimír Bartoš, Milada Kullová
Format: Article
Language:English
Published: Karolinum Press 2017-06-01
Series:Acta Medica
Subjects:
Online Access:https://actamedica.lfhk.cuni.cz/60/1/0032/
_version_ 1819155293110534144
author Vladimír Bartoš
Milada Kullová
author_facet Vladimír Bartoš
Milada Kullová
author_sort Vladimír Bartoš
collection DOAJ
description Background: P120(ctn) is a specific membranous adhesion protein, that maintains the stability of intercellular junctions. An altered expression of p120(ctn), either reduced in the cell membrane or increase in the cytoplasm, plays a crucial role in carcinogenesis. No research has analysed the expression of p120(ctn) in basal cell carcinoma (BCC) of the skin so far. Therefore, we immunohistochemically studied p120(ctn) in a set of cutaneous BCCs in order to determine, whether there is difference in the expression pattern related to the histologic subtypes and tumor growth characteristics. Material and Methods: The study group consisted of 38 BCCs cathegorized into low-risk (non-infiltrative) subroup (8 superficial and 12 nodular subtypes) and high-risk (infiltrative) subgroup (10 nodular-infiltrative and 8 infiltrative subtypes). Specific monoclonal antibody against p120(ctn) was used for staining. Results: Overall, there were 12 cases (31.6%) with normal preserved and 26 cases (68.4%) with abnormal p120(ctn) expression. In superficial, nodular, nodular-infiltrative and infiltrative subtypes, abnormal p120(ctn) immunoreactivity was found in 37.5% (3/8), 41.7% (5/12), 100% (10/10) and 100% (8/8), respectively. We have confirmed a strong correlation between the expression of p120(ctn) and both given, non-infiltrative and infiltrative BCC growth phenotypes. In the latter subgroup, almost all lesions showed diffusely reduced membranous staining, of which five also manifested an aberrant immunoreactivity in the cytoplasm. This cytoplasmic positivity occurred solely at the invasive front of the infiltrative tumor formations. Conclusion: Our results showed that decreased membranous expression of p120(ctn) was a frequent event in human cutaneous BCC and it was associated with infiltrative growth phenotype. Considering that nearly half of the BCCs with non-infiltrative growth pattern also exhibited reduced membranous expression, aberrant cytoplasmic immunoreactivity of p120(ctn), which was found exclusively in the high-risk BCC variants, can more reliably reflect and predict biological behaviour and malignant potential.
first_indexed 2024-12-22T15:34:40Z
format Article
id doaj.art-4d099ba9d3044efeb8191325bf5db0b5
institution Directory Open Access Journal
issn 1211-4286
1805-9694
language English
last_indexed 2024-12-22T15:34:40Z
publishDate 2017-06-01
publisher Karolinum Press
record_format Article
series Acta Medica
spelling doaj.art-4d099ba9d3044efeb8191325bf5db0b52022-12-21T18:21:17ZengKarolinum PressActa Medica1211-42861805-96942017-06-01601323610.14712/18059694.2017.485145Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the SkinVladimír BartošMilada KullováBackground: P120(ctn) is a specific membranous adhesion protein, that maintains the stability of intercellular junctions. An altered expression of p120(ctn), either reduced in the cell membrane or increase in the cytoplasm, plays a crucial role in carcinogenesis. No research has analysed the expression of p120(ctn) in basal cell carcinoma (BCC) of the skin so far. Therefore, we immunohistochemically studied p120(ctn) in a set of cutaneous BCCs in order to determine, whether there is difference in the expression pattern related to the histologic subtypes and tumor growth characteristics. Material and Methods: The study group consisted of 38 BCCs cathegorized into low-risk (non-infiltrative) subroup (8 superficial and 12 nodular subtypes) and high-risk (infiltrative) subgroup (10 nodular-infiltrative and 8 infiltrative subtypes). Specific monoclonal antibody against p120(ctn) was used for staining. Results: Overall, there were 12 cases (31.6%) with normal preserved and 26 cases (68.4%) with abnormal p120(ctn) expression. In superficial, nodular, nodular-infiltrative and infiltrative subtypes, abnormal p120(ctn) immunoreactivity was found in 37.5% (3/8), 41.7% (5/12), 100% (10/10) and 100% (8/8), respectively. We have confirmed a strong correlation between the expression of p120(ctn) and both given, non-infiltrative and infiltrative BCC growth phenotypes. In the latter subgroup, almost all lesions showed diffusely reduced membranous staining, of which five also manifested an aberrant immunoreactivity in the cytoplasm. This cytoplasmic positivity occurred solely at the invasive front of the infiltrative tumor formations. Conclusion: Our results showed that decreased membranous expression of p120(ctn) was a frequent event in human cutaneous BCC and it was associated with infiltrative growth phenotype. Considering that nearly half of the BCCs with non-infiltrative growth pattern also exhibited reduced membranous expression, aberrant cytoplasmic immunoreactivity of p120(ctn), which was found exclusively in the high-risk BCC variants, can more reliably reflect and predict biological behaviour and malignant potential.https://actamedica.lfhk.cuni.cz/60/1/0032/basal cell carcinomabiological behaviourP120catenin
spellingShingle Vladimír Bartoš
Milada Kullová
Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin
Acta Medica
basal cell carcinoma
biological behaviour
P120catenin
title Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin
title_full Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin
title_fullStr Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin
title_full_unstemmed Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin
title_short Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin
title_sort investigation of p120catenin expression in human basal cell carcinoma of the skin
topic basal cell carcinoma
biological behaviour
P120catenin
url https://actamedica.lfhk.cuni.cz/60/1/0032/
work_keys_str_mv AT vladimirbartos investigationofp120cateninexpressioninhumanbasalcellcarcinomaoftheskin
AT miladakullova investigationofp120cateninexpressioninhumanbasalcellcarcinomaoftheskin